BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Diagnosis
4699 results:

  • 1. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
    Abdulla M
    Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Timing, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumors.
    Gomella PT; Solomon J; Ahdoot M; Gurram S; Lebastchi AH; Levy E; Krishnasamy V; Kassin MT; Chang R; Wood BJ; Linehan WM; Ball MW
    Urol Oncol; 2024 Jul; 42(7):222.e1-222.e7. PubMed ID: 38614921
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas.
    Xu Y; Zhang X; Xia Q; Zhou Y; Wang X; Fang R; Wang Y; Tong Q; Chen J; Shi J; Fu Y; Rao Q
    Am J Surg Pathol; 2024 Jun; 48(6):662-670. PubMed ID: 38595297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
    Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
    J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histomorphometric and Immunohistochemical diagnosis of Renal Cell Carcinoma: Review Article.
    Deka D; Chakravarty M
    Mymensingh Med J; 2024 Apr; 33(2):636-642. PubMed ID: 38557550
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies.
    Shi X; Deng G; Wen H; Lin A; Wang H; Zhu L; Mou W; Liu Z; Li X; Zhang J; Cheng Q; Luo P
    J Glob Health; 2024 Mar; 14():04067. PubMed ID: 38547495
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. National clinical and financial outcomes associated with acute kidney injury following esophagectomy for cancer.
    Ng AP; Chervu N; Branche C; Bakhtiyar SS; Marzban M; Toste PA; Benharash P
    PLoS One; 2024; 19(3):e0300876. PubMed ID: 38547215
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential diagnosis of rare adrenal cellular schwannomas: A case report.
    Chen J; Huang Y; Chen J; Qi X; Ma Y; Wang M; Liu F
    Medicine (Baltimore); 2024 Mar; 103(12):e37452. PubMed ID: 38518040
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
    Gong X; Gong Y; Wu G; Ke H
    Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Recurrent bladder leiomyoma: a case report.
    Yogeeta F; Malik Z; Rauf SA; Devi M; Tooba F; Jamalvi SA; Rashid M; Erum H
    J Med Case Rep; 2024 Mar; 18(1):173. PubMed ID: 38515215
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
    Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
    JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
    Baard J; Cormio L; Dasgupta R; Maruzzi D; Rais-Bahrami S; Serrano A; Geavlete B; Giannakopoulos S; de la Rosette J; Laguna P
    World J Urol; 2024 Mar; 42(1):177. PubMed ID: 38507109
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
    Palermo M; D'Elia C; Trenti E; Comploj E; Mian C; Schwienbacher C; Heidegger I; Clauser S; Pycha A; Vjaters E
    Minerva Urol Nephrol; 2024 Apr; 76(2):195-202. PubMed ID: 38498297
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.
    Korkmaz M; Eryılmaz MK; Koçak MZ; Er MM; Hendem E; Demirkıran A; Araz M; Artaç M
    Eur J Clin Pharmacol; 2024 Jun; 80(6):941-947. PubMed ID: 38478093
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Enhanced Artificial Intelligence Strategies in Renal Oncology: Iterative Optimization and Comparative Analysis of GPT 3.5 Versus 4.0.
    Liang R; Zhao A; Peng L; Xu X; Zhong J; Wu F; Yi F; Zhang S; Wu S; Hou J
    Ann Surg Oncol; 2024 Jun; 31(6):3887-3893. PubMed ID: 38472675
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases.
    Wu Q; Hatse S; Kenis C; Fernández-García J; Altea-Manzano P; Billen J; Planque M; Vandekeere A; Lambrechts Y; Richard F; Punie K; Neven P; Smeets A; Nevelsteen I; Floris G; Desmedt C; Gomes AP; Fendt SM; Wildiers H
    Breast Cancer Res Treat; 2024 Jun; 205(3):555-565. PubMed ID: 38472594
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intra-Abdominal Epithelioid Neoplasm With EWSR1::CREB Fusions Involving the kidney: A Clinicopathologic and Molecular Characterization With an Emphasis on Differential diagnosis.
    Zhao M; Gan H; Zhong S; Xia Q; Bai Y; Xu J; Teng X; Wang J
    Mod Pathol; 2024 May; 37(5):100468. PubMed ID: 38460673
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 235.